Kush Parmar - 02 Jan 2024 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Director
Signature
/s/ Michael Greco, Attorney-in-Fact
Issuer symbol
RLYB
Transactions as of
02 Jan 2024
Net transactions value
+$47,999
Form type
4
Filing time
04 Jan 2024, 17:58:14 UTC
Previous filing
12 Jun 2023
Next filing
17 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLYB Option (Right to Buy) Award $47,999 +27,118 $1.77 27,118 02 Jan 2024 Common Stock 27,118 $2.40 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to the underlying shares of Common Stock in 12 equal installments, each on the last day of each month of calendar year 2024.
F2 This option was issued to the reporting person pursuant to the Company's 2021 Equity Incentive Plan in lieu of retainer fees of $48,000.